tirzepatide stock price BREAKING: Eli Lilly (LLY) nears $1,000,000,000,000 market cap as shares jump over 4% today after Novo Nordisk's weight-loss drug, CagriSema, failed to outperform Eli Lilly's Zepbound (tirzepatide) in a Phase 3 trial Mounjaro (Tirzepatide) — 8-Week Weight
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15



























